Skip to content

To compare the effect of lignocaine gel versus lignocaine spray in addition to ibuprofen in reducing pain during hysterosalpingography in primary or secondary infertile women

Comparative Study of lignocaine gel versus lignocaine spray in addition to ibuprofen in pain management during hysterosalpingography - A Randomised controlled study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101351
Enrollment
128
Registered
2026-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N971- Female infertility of tubal origin

Interventions

Intervention1: Lignocaine gel applied on cervix along with tab ibuprofen p/o: 400mg tab ibuprofen taken p/o 1 hour before the procedure with lignocaine gel 10% 1gm applied on cervix 10minutes before t

Sponsors

Monika Kumari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All infertile women with primary or secondary infertility planned for hysterosalpingography

Exclusion criteria

Exclusion criteria: active vaginitis , PID , tubo ovarian mass , hydrosalpinx , active pelvic infections (TB) , h/o atopy to dye

Design outcomes

Primary

MeasureTime frame
1.Comparing lignocaine gel and lignocaine spray plus ibuprofen for analgesia after 30min of procedure of hysterosalpingography as measured by the numerical rating scaleTimepoint: 9-12months

Secondary

MeasureTime frame
1.To assess efficacy in relieving pain specifically during application of teneculum between control (lignocaine and intervention arm 2. To assess efficacy in relieving pain during contrast dye instillation between control and intervention armTimepoint: 9-12months

Countries

India

Contacts

Public ContactShamshad ahmad

AIIMS PATNA

indiralh@gmail.com8860033085

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026